Results 1 to 8 of 8
Page 1 of 1
TypeTitleAuthor(s)YearViews
Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovirLeung, N; Peng, CY; Hann, HW; Sollano, J; LaoTan, J; Hsu, CW; Lesmana, L; Yuen, MF; Jeffers, L; Sherman, M; Min, A; Mencarini, K; Diva, U; Cross, A; Wilber, R; LopezTalavera, J2009418
 
Entecavir (ETV) Results in Higher HBV-DNA Reduction vs Adefovir (ADV) In Chronically Infected HBeAg(+) Antiviral-Naive Adults: 48-Week Results (E.A.R.L.Y. STUDY)Leung, N; Sherman, M; Peng, CY; Sollano, JD; Lesmana, L; Yuen, RMF; Jeffers, L; Hann, HW; Menearini, K; Colonno, R; Cross, A; Wilber, R; Lopez-Talavera, JC200797
 
Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trialChan, HLY; Heathcote, EJ; Marcellin, P; Lai, CL; Cho, M; Moon, YM; Chao, YC; Myers, RP; Minuk, GY; Jeffers, L; Sievert, W; Bzowej, N; Harb, G; Kaiser, R; Qiao, XJ; Brown, NA; Crawford, D; Lim, SG; Chutaputti, A; Poynard, T2007143
 
A Randomized Trial of Telbivudine (LdT) vs Adefovir for HBeAg-positive Chronic Hepatitis B: Final Week 52 resultsBzowej, N; Chan, HLY; Lai, CL; Cho, M; Moon, YM; Chao, YC; Heathcote, EJ; Myers, R; Minuk, G; Marcellin, P; Jeffers, L; Sievert, W; Kaiser, R; Harb, G; Chao, GC; Brown, NA2006164
 
A Randomized Trial of Telbivudine (LdT) vs Adefovir for HBeAg-positive Chronic Hepatitis B: Results of the Primary Week 24 AnalysisHeathcote, EJ; Chan, HL; Cho, M; Lai, CL; Moon, YM; Chao, YC; Myers, R; Minuk, G; Marcellin, P; Jeffers, L; Sievert, W; Kaiser, R; Chao, G; Brown, N2006110
 
A randomized trial of telbivudine (LDT) vs. adefovir for HBeAg-positive chronic hepatitis B: Results of the primary week 24 analysisChan, HLY; Lai, CL; Cho, M; Heathcote, J; Moon, Y-M; Chao, Y-C; Myers, R; Minuk, G; Marcellin, P; Jeffers, L; Sievert, W; Kaiser, R; Chao, G; Brown, N2006117
 
Entecavir results in higher HBV DNA reduction vs adefovir in chronically infected HBeAg(+) antiviral-naive adults: 24 wk results (EARLY study)Leung, N; Peng, CY; Sollano, J; Lesmana, L; Yuen, RMF; Jeffers, L; Han, HW; Sherman, M; Zhu, J; Menearini, K; Colonno, RJ; Cross, A; Wilber, R; Lopez-Talavera, JC2006136
 
Entecavir (ETV) vs. Adefovir (ADV): HBV DNA reduction of viral load in chronically infected HBeAg(+) nucleoside naive adults in a 12-weekSherman, M; Hann, HW; Jeffers, L; Min, A; Leung, N; Peng, CY; Liaw, YF; Sollano, J; Lesmana, L; Yuen, RMF; Zhu, J; Mencarini, K; Colonno, R; Cross, A; Wilber, R; Lopez-Talavera, JC2006122
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download